Despite multiples challenges, the completed device has proven to consistently execute the assays through precise control of liquids on a microfluidic scale. Owing to its portable nature, support of patient self-sampling and rapid reading of results, the device is set to drastically improve pathways into the healthcare system for thousands of hard-to-reach communities of women across the globe.

The solution is a portable, point-of-care HPV testing device that yields rapid, easy-to-understand results, without relying on trained medical personnel. The device is capable of completely automated detection of 14 HPV strains and 2 proteomic biomarkers, with the only end-user intervention being introduction of the self-sample swab. Able to obtain a patients’ result ‘while-you-wait’ the device provides quantitative information of each of the HPV strains and the proteins.